Chemotherapy: Managing side effects and safe handling

Canadian Veterinary Journal

Volumn 50, Issue 6, 2009, Pages 665-668

  Macdonald, Valerie ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; ANIMAL DISEASE; ANIMAL WELFARE; ARTICLE; NEOPLASM; ONCOLOGY; QUALITY OF LIFE; STANDARD; VETERINARY MEDICINE;

ANIMAL WELFARE; ANIMALS; ANTINEOPLASTIC AGENTS; MEDICAL ONCOLOGY; NEOPLASMS; QUALITY OF LIFE; VETERINARY MEDICINE;

EID: 68149138708     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Chun R., Garret I, Vail D. Cancer chemotherapy. In: Withrow SJ, Vail DM, eds. Withrow & MacEwen's Small Animal Clinical Oncology. 4th ed. Philadelphia: WB Saunders, 2007:163-192.
2. Group VCO. Veterinary Co-operative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v 1.0. Vet Compar Oncol 2004; 2:194-213.
3. DeVita VT, Chu E. Principles of Medical Oncology. In: DeVita, Hellman & Rosenberg's Cancer Principles & Practice of Oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:337-350.
4. Kisseberth WC, MacEwen EG. Complications of Cancer and Its Treatment. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: Saunders, 2001:198-232.
5. Van de Wetering MD, de Witte MA, Kremer LCM, Offringa M., Scholten RJPM, Caron HN. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: A systematic review of randomized controlled trials. Eur J of Cancer 2005; 41:1372-1382.
6. Chretin JD, Rassnick KM, Shaw NA, et al. Prophylactic trimethoprimsulfadiazine during chemotherapy in dogs with lymphoma and ostoesarcoma: A double-blind, placebo-controlled study. J Vet Intern Med 2007; 21: 141-148.